# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-011553
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:09
Documents
4
Period of Report
2022-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14-a.htm | DEF 14A | 533179
2 |  | formdef14a_001.jpg | GRAPHIC | 5171
3 |  | proxy_001.jpg | GRAPHIC | 441395
4 |  | proxy_002.jpg | GRAPHIC | 426038
| Complete submission text file | 0001493152-22-011553.txt |  | 1735820

Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40738 | Film No.: 22875186
SIC: 2834 Pharmaceutical Preparations